Cargando…

The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients

BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lun, Zhubin, Liu, Liwei, Chen, Guanzhong, Ying, Ming, Liu, Jin, Wang, Bo, Liang, Jingjing, Yang, Yongquan, Chen, Shiqun, He, Yibo, Chung, Edmund Y. M., Chen, Jiyan, Ye, Jianfeng, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494686/
https://www.ncbi.nlm.nih.gov/pubmed/34076881
http://dx.doi.org/10.1007/s40620-021-01021-1
_version_ 1784579367535378432
author Lun, Zhubin
Liu, Liwei
Chen, Guanzhong
Ying, Ming
Liu, Jin
Wang, Bo
Liang, Jingjing
Yang, Yongquan
Chen, Shiqun
He, Yibo
Chung, Edmund Y. M.
Chen, Jiyan
Ye, Jianfeng
Liu, Yong
author_facet Lun, Zhubin
Liu, Liwei
Chen, Guanzhong
Ying, Ming
Liu, Jin
Wang, Bo
Liang, Jingjing
Yang, Yongquan
Chen, Shiqun
He, Yibo
Chung, Edmund Y. M.
Chen, Jiyan
Ye, Jianfeng
Liu, Yong
author_sort Lun, Zhubin
collection PubMed
description BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after coronary angiography. METHODS: We searched Medline, Embase, and Cochrane Database of Systematic Reviews (to 30th June 2019). We evaluated the world’s incidence of the CA-AKI, and associated mortality, and to described geographic variations according to countries, regions, and economies. CA-AKI was defined as an increase in serum creatinine ≥ 0.5 mg/dl or ≥ 25% within 72 h. Random effects model meta-analyses and meta-regressions was performed to derive the sources of heterogeneity. RESULTS: A total of 134 articles (1,211,106 participants) were included in our meta-analysis. Most studies originated from China, Japan, Turkey and United States, from upper middle income and high income countries. The pooled incidence of CA-AKI after coronary angiography was 12.8% (95% CI 11.7–13.9%), and the CA-AKI associated mortality was 20.2% (95% CI 10.7–29.7%). The incidence of CA-AKI and the CA-AKI associated mortality were not declined over time (Incidence rate change: 0.23% 95% CI − 0.050 to 0.510 p = 0.617; Mortality rate change: − 1.05% 95% CI − 3.070 to 0.970 p = 0.308, respectively). CONCLUSION: CA-AKI was a universal complication in many regions, and the burden of CA-AKI remains severe. In clinical practice, physicians should pay more attention to the occurrence and active prevention and treatment of CA-AKI. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01021-1.
format Online
Article
Text
id pubmed-8494686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84946862021-10-19 The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients Lun, Zhubin Liu, Liwei Chen, Guanzhong Ying, Ming Liu, Jin Wang, Bo Liang, Jingjing Yang, Yongquan Chen, Shiqun He, Yibo Chung, Edmund Y. M. Chen, Jiyan Ye, Jianfeng Liu, Yong J Nephrol Original Article BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after coronary angiography. METHODS: We searched Medline, Embase, and Cochrane Database of Systematic Reviews (to 30th June 2019). We evaluated the world’s incidence of the CA-AKI, and associated mortality, and to described geographic variations according to countries, regions, and economies. CA-AKI was defined as an increase in serum creatinine ≥ 0.5 mg/dl or ≥ 25% within 72 h. Random effects model meta-analyses and meta-regressions was performed to derive the sources of heterogeneity. RESULTS: A total of 134 articles (1,211,106 participants) were included in our meta-analysis. Most studies originated from China, Japan, Turkey and United States, from upper middle income and high income countries. The pooled incidence of CA-AKI after coronary angiography was 12.8% (95% CI 11.7–13.9%), and the CA-AKI associated mortality was 20.2% (95% CI 10.7–29.7%). The incidence of CA-AKI and the CA-AKI associated mortality were not declined over time (Incidence rate change: 0.23% 95% CI − 0.050 to 0.510 p = 0.617; Mortality rate change: − 1.05% 95% CI − 3.070 to 0.970 p = 0.308, respectively). CONCLUSION: CA-AKI was a universal complication in many regions, and the burden of CA-AKI remains severe. In clinical practice, physicians should pay more attention to the occurrence and active prevention and treatment of CA-AKI. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01021-1. Springer International Publishing 2021-06-02 2021 /pmc/articles/PMC8494686/ /pubmed/34076881 http://dx.doi.org/10.1007/s40620-021-01021-1 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Lun, Zhubin
Liu, Liwei
Chen, Guanzhong
Ying, Ming
Liu, Jin
Wang, Bo
Liang, Jingjing
Yang, Yongquan
Chen, Shiqun
He, Yibo
Chung, Edmund Y. M.
Chen, Jiyan
Ye, Jianfeng
Liu, Yong
The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title_full The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title_fullStr The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title_full_unstemmed The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title_short The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
title_sort global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494686/
https://www.ncbi.nlm.nih.gov/pubmed/34076881
http://dx.doi.org/10.1007/s40620-021-01021-1
work_keys_str_mv AT lunzhubin theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liuliwei theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenguanzhong theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yingming theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liujin theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT wangbo theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liangjingjing theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yangyongquan theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenshiqun theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT heyibo theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chungedmundym theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenjiyan theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yejianfeng theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liuyong theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT lunzhubin globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liuliwei globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenguanzhong globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yingming globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liujin globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT wangbo globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liangjingjing globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yangyongquan globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenshiqun globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT heyibo globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chungedmundym globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT chenjiyan globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT yejianfeng globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients
AT liuyong globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients